Does androgen suppression enhance the efficacy of postoperative irradiation? A secondary analysis of RTOG 85-31. Radiation Therapy Oncology Group. [electronic resource]
Producer: 19991004Description: 495-502 p. digitalISSN:- 1527-9995
- Adenocarcinoma -- blood
- Aged
- Aged, 80 and over
- Antineoplastic Agents, Hormonal -- therapeutic use
- Combined Modality Therapy
- Disease-Free Survival
- Follow-Up Studies
- Goserelin -- therapeutic use
- Humans
- Male
- Middle Aged
- Prospective Studies
- Prostate-Specific Antigen -- blood
- Prostatic Neoplasms -- blood
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.